Ownership Summary
Recent 13F filings as of September 2025 show that 4 institutional investors hold a position in Advanced Biomed Inc. (NASDAQ:ADVB).
- The percentage of Advanced Biomed owned by institutions changed from 0.3% in June 2025 to 1.0% in September 2025, marking a slight up trend.
- In percentage terms, this reflects as a holdings change of 249.14% quarter on quarter, and an unavailable change year over year.
- The latest 13F cycle for Advanced Biomed reveals that of 4 total investors, 3 funds grew their exposure, whereas 1 reduced theirs and 0 made no changes.
- The aggregate institutional position in Advanced Biomed now stands at 210.60K shares as of September 2025, after investors increased their holdings (up by 150.28K shares quarter on quarter which is down N/A shares year over year).
- With 139.51K shares, CITADEL ADVISORS LLC commands the largest institutional position in Advanced Biomed as of September 30, 2025, equating to 0.64% of the company.
- Among the most significant buyers of Advanced Biomed during September 2025 were CITADEL ADVISORS LLC (128.30K), HRT FINANCIAL LP (35.68K), Virtu Financial LLC (7.77K).
- Leading sellers of Advanced Biomed stock in September 2025 included UBS Group AG (21.47K).
- The top 4 institutional holders of Advanced Biomed for the quarter ending September 2025 included CITADEL ADVISORS LLC (139.51K), HRT FINANCIAL LP (35.68K), Virtu Financial LLC (32.05K), UBS Group AG (3.36K).